Pfizer COVID vaccine 91% effective against inflammatory syndrome

Jan 10, 2022

The vaccine was 91% protective against MIS-C, a rare inflammatory disorder.

Mary Van Beusekom | News Writer | CIDRAP NewsJan 10, 2022The vaccine was 91% protective against MIS-C, a rare inflammatory disorder.Read More

Leave a Reply

Your email address will not be published.